Fed's Warsh Sparks Bond Selloff, Apple Warns of '100-Year' Memory Flood: What Moved Markets This Week...
Financial News Archive
SEC EDGAR · Federal Reserve · FDA · BLS · Updated every 60s
Amgen Identifies Unauthorized Activity In Third-party Cloud Environments In July 2026; Reports No Impact To Products, Operations, Or Financial Reporti...
'OpenAI Investigators Find Evidence That Other AI Agents Escaped Containment, Sources Say' - Reuters Exclusive...
Bernstein Maintains Outperform on Walmart, Lowers Price Target to $142...
$100 Invested In Visa 15 Years Ago Would Be Worth This Much Today...
$1000 Invested In Home Depot 15 Years Ago Would Be Worth This Much Today...
DR REDDYS LABS SA announced Friday the FDA approval of its undisclosed commercial drug application, with the pivotal regulatory milestone set to signi...
Gland Pharma Limited has received FDA approval for its Atropine Sulfate ophthalmic product, issuing new competition for the branded segment. Patients ...
KLM LABS PVT announced today that the FDA has approved its ANDA220017 for the targeted substance, marking a potential expansion of its product portfol...
Institutional holdings report (13F-HR) filed by Japan Science & Technology Agency....
Institutional holdings report (13F-HR) filed by Aviance Capital Partners, LLC....
Institutional holdings report (13F-HR) filed by Worth Financial Advisory Group, LLC....
Institutional holdings report (13F-HR) filed by Axiom Investment Management LLC....
Institutional holdings report (13F-HR) filed by AOZORA BANK, LTD.....
Institutional holdings report (13F-HR) filed by Phocas Financial Corp.....
Institutional holdings report (13F-HR) filed by Creekside Partners....
Bain Capital Specialty Finance filed an 8-K to propose a Fourth Amendment to its Senior Secured Revolving Credit Agreement, setting the Amendment Effe...
Institutional holdings report (13F-HR) filed by Drum Hill Capital, LLC....
Tredegar Corporation announced Frasier Brickhouse II, CFO and Treasurer, plans to retire effective September 1, 2026. A smooth transition plan is curr...
RP1's IGNYTE study efficacy results were deemed evaluable and clinically meaningful by the FDA's Cell, Tissue, and Gene Therapies Advisory Committee. ...